Indaptus Therapeutics, Inc. (INDP) vs Century Therapeutics, Inc. (IPSC)
A side-by-side comparison of Indaptus Therapeutics, Inc. and Century Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INDP
Indaptus Therapeutics, Inc.
$2.50HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
IPSC
Century Therapeutics, Inc.
$1.35HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — INDP vs IPSC
growth of $100 · dividends reinvested · last 5yINDP -99.5% (-66.0%/yr)IPSC -93.5% (-42.1%/yr)IPSC compounded faster over this window
Log scale — wide-divergence pair
INDP IPSC
INDP vs IPSC: by the numbers
- •INDP is the larger company ($283M vs $244M market cap).
- •Both run net losses; INDP's is the smaller (0.00% vs -8.78% net margin).
Metrics side by side
Valuation
| Metric | INDP | IPSC |
|---|---|---|
| P/B ratio | 24.89 | 1.05 |
Profitability
| Metric | INDP | IPSC |
|---|---|---|
| Gross margin | 0.00% | 88.00% |
| Operating margin | 0.00% | -13.78% |
| Net margin | 0.00% | -8.78% |
| ROE | -135.62% | -47.25% |
| ROIC | -129.90% | -43.69% |
Growth (annualized)
| Metric | INDP | IPSC |
|---|---|---|
| Total return CAGR (5Y) | -58.32% | -42.05% |
Frequently asked
- How have INDP and IPSC total returns compared?
- Over the past 5 years, INDP delivered -58.32% and IPSC delivered -42.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.